Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001739104-25-000055
Filing Date
2025-08-07
Accepted
2025-08-07 09:05:13
Documents
75
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q elan-20250630.htm   iXBRL 10-Q 1171510
2 EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex311elanco-20250630xceoce.htm EX-31.1 10266
3 EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER ex312elanco-20250630xcfoce.htm EX-31.2 10294
4 EX-32 - CERTIFICATIONS OF CEO AND CFO ex32elanco-20250630xsectio.htm EX-32 8800
10 GRAPHIC elan-20250630_g1.jpg GRAPHIC 68307
  Complete submission text file 0001739104-25-000055.txt   6470729

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elan-20250630.xsd EX-101.SCH 42941
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elan-20250630_cal.xml EX-101.CAL 64297
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elan-20250630_def.xml EX-101.DEF 205209
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elan-20250630_lab.xml EX-101.LAB 550138
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elan-20250630_pre.xml EX-101.PRE 376730
78 EXTRACTED XBRL INSTANCE DOCUMENT elan-20250630_htm.xml XML 881587
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38661 | Film No.: 251191971
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)